Trial Profile
Efficacy and Safety of a Single-dose Regimen and a Multi-dose Regimen of Mebendazole Against Hookworm Infections in Children and Adolescents in Ghana: a Randomized Controlled Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2017
Price :
$35
*
At a glance
- Drugs Mebendazole (Primary)
- Indications Hookworm infections
- Focus Therapeutic Use
- 15 Nov 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 29 Aug 2017 New trial record